King appointed POD 5 Physician Leader
Ryan King, MD, PhD has been appointed as an Anesthesiology Physician Leader in POD 5 at Barnes-Jewish Hospital (BJH).
Moquin appointed Vice Chair for Academic Affairs and Professional Development
Following an open search and a competitive interview process, I am pleased to announce the appointment of Rachel Moquin, EdD, as Vice Chair for Academic Affairs and Professional Development in the Department of Anesthesiology at WashU Medicine. In this new executive leadership role, Dr. Moquin will lead the department’s Office of Professional Growth and Engagement—an […]
Six APPs named finalists for 2025 March of Dimes Heroes in Action Awards
The Department of Anesthesiology is proud to announce that six of its Advanced Practice Providers (APPs) have been named finalists for the March of Dimes Heroes in Action 2025 awards.
Drewry named inaugural Llorin-Roa Professor of Anesthesiology
Anne Drewry, MD, MS, Vice Chair and Division Chief of Critical Care Medicine, has been appointed the inaugural Llorin-Roa Professor of Anesthesiology.
Two anesthesiology faculty recognized by the Academy of Educators
At this year’s Education Day, Dr. Allison Mitchell was inducted as a new member of the Academy and Dr. Rachel Moquin received the Rising Star Award.
Celebrating Inclusive Behaviors: Anesthesiology Department Recognizes SAFE Reporting Accolade Recipients
The Department of Anesthesiology is proud to recognize team members who have received accolades through the SAFE (Supporting a Fair Environment) Reporting platform.
St. Louis Pain Research Forum Fosters Collaboration and Discovery
Scientists, clinicians, and trainees gathered at the University of Health Sciences and Pharmacy in St. Louis (UHSP) this past September for the second St. Louis Translational Pain Research Forum (STL-TPRF), an event designed to foster collaboration and mentorship within the region’s growing pain research community.
Personalized brain modeling of anesthetic effects to predict antidepressant response (Links to an external site)
With funding from the National Institutes of Health (NIH), ShiNung Ching and Ben Palanca seek to develop personalized medicine strategies for treatment-resistant depression that would tailor drug dosage based on a patient’s age, genetics, health conditions, brain dynamics and neural circuits.